Avience Biomedicals (NSE:AVIENCE) Interest Expense: ₹0.0 Mil (TTM As of Jan. 2026)


NSE:AVIENCE Avience Biomedicals Ltd NSE:AVIENCE
5 GF Score
Price ₹414.95
View Full Analysis

What is Avience Biomedicals Interest Expense?

Avience Biomedicals NSE:AVIENCE 5 Interest Expense is ₹0.0 Mil as of Jan. 2026. GuruFocus rates NSE:AVIENCE with a GF Score™ of 5/100.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Avience Biomedicals's interest expense for the three months ended in Jan. 2026 was ₹ 0.0 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jan. 2026 was ₹0.0 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Avience Biomedicals's Operating Income for the three months ended in Jan. 2026 was ₹ 0.0 Mil. Avience Biomedicals's Interest Expense for the three months ended in Jan. 2026 was ₹ 0.0 Mil. GuruFocus does not calculate Avience Biomedicals's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Avience Biomedicals  (NSE:AVIENCE) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Avience Biomedicals's Interest Expense for the three months ended in Jan. 2026 was ₹0.0 Mil. Its Operating Income for the three months ended in Jan. 2026 was ₹0.0 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jan. 2026 was ₹119.2 Mil.

Avience Biomedicals's Interest Coverage for the quarter that ended in Jan. 2026 is calculated as

GuruFocus does not calculate Avience Biomedicals's interest coverage with the available data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Avience Biomedicals Interest Expense Historical Data

* Premium members only.

The historical data trend for Avience Biomedicals's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avience Biomedicals Interest Expense Chart

Avience Biomedicals Annual Data
Trend Mar23 Mar24 Mar25
Interest Expense
-2.43 -8.90 -13.79

Avience Biomedicals Quarterly Data
Mar23 Mar24 Mar25 Jan26
Interest Expense 0.00 0.00 0.00 0.00
NSE:AVIENCE
5GF Score
Avience Biomedicals Ltd NSE:AVIENCE
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Avience Biomedicals Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of ₹0.0 Mil mean?
Avience Biomedicals (NSE:AVIENCE) has a Interest Expense of ₹0.0 Mil as of Jan. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Avience Biomedicals and its competitors.
Is Avience Biomedicals' Interest Expense too high?
Avience Biomedicals' current Interest Expense is ₹0.0 Mil. Overall, Avience Biomedicals has a GF Score™ of 5/100, reflecting its overall financial health beyond just this single metric.
How does Avience Biomedicals' Interest Expense compare to ABT and SYK?
Avience Biomedicals' Interest Expense of ₹0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Medical Devices & Instruments company?
A good Interest Expense depends on the Medical Devices & Instruments industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Avience Biomedicals and its competitors. Avience Biomedicals's current Interest Expense is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avience Biomedicals stock overvalued right now?
Avience Biomedicals (NSE:AVIENCE) has a current Interest Expense of ₹0.0 Mil. The current Interest Expense is ₹0.0 Mil. Avience Biomedicals' overall GF Score™ is 5/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Avience Biomedicals (NSE:AVIENCE), the current Interest Expense is ₹0.0 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Avience Biomedicals Business Description

Address C-11, Block-C, Community Centre, Unit No-2, 1st Floor, Janakpuri A-3, New Delhi, IND, 110058
Avience Biomedicals Ltd is a medical consumables company focused on the manufacturing of Vitro-Diagnostic (IVD) products and medical devices. Its product offerings include diagnostic solutions used for the detection of diseases, conditions, and infections across laboratory, healthcare, and home-use applications. The company operates in areas including molecular biotechnology, genomics, and diagnostic products, and also provides distribution services for medical technology products in India. Its revenue is generated from Manufactured Goods and Traded Goods and Services, which include the sale of Medical Devices and Consumables.
5GF Score

Get the complete analysis for NSE:AVIENCE

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹414.95
Price